Primary tabs

Developing Novel Transgenic Strategies for Introducing Dengue Virus Refractivity in Mosquito Cells and Tissues

Dr. Fraser's team is working to develop and test new approaches to suppressing the replication of dengue virus in the cells of its primary vector, Aedes aegypti mosquitoes. The team is using genetic strategies to introduce a molecular mechanism that uses the dengue virus' own genetic make-up to initiate a process that results in the death of infected cells in the mosquitoes, limiting their ability to transmit disease. In addition, investigators are working on tools to enhance the application of this and other genetic strategies in mosquitoes.

Grant ID
777 FRASER05GCGH0
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
2500000.00
Funding Currency
USD
Funding Amount (in USD)
2500000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
2500000.00
Co-Funded
False